The DOI matches its Crossref record; 94 of the 98 references it cites were found in a registry or an index.
Adrenal Insufficiency in Corticosteroids Use: Systematic Review and Meta-Analysis
Abstract
OBJECTIVE: We aimed to estimate pooled percentages of patients with adrenal insufficiency after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we aimed to stratify the results by route of administration, disease, treatment dose, and duration. METHODS: We searched seven electronic databases (PubMed, MEDLINE, EMBASE, COCHRANE, CENTRAL, Web of Science, and CINAHL/Academic Search Premier) in February 2014 to identify potentially relevant studies. Original articles testing adult corticosteroid users for adrenal insufficiency were eligible. RESULTS: We included 74 articles with a total of 3753 participants. Stratified by administration form, percentages of patients with adrenal insufficiency ranged from 4.2% for nasal administration (95% confidence interval [CI], 0.5-28.9) to 52.2% for intra-articular administration (95% CI, 40.5-63.6). Stratified by disease, percentages ranged from 6.8% for asthma with inhalation corticosteroids only (95% CI, 3.8-12.0) to 60.0% for hematological malignancies (95% CI, 38.0-78.6). The risk also varied according to dose from 2.4% (95% CI, 0.6-9.3) (low dose) to 21.5% (95% CI, 12.0-35.5) (high dose), and according to treatment duration from 1.4% (95% CI, 0.3-7.4) (<28 d) to 27.4% (95% CI, 17.7-39.8) (>1 year) in asthma patients. CONCLUSIONS: 1) Adrenal insufficiency after discontinuation of glucocorticoid occurs frequently; 2) there is no administration form, dosing, treatment duration, or underlying disease for which adrenal insufficiency can be excluded with certainty, although higher dose and longer use give the highest risk; 3) the threshold to test corticosteroid users for adrenal insufficiency should be low in clinical practice, especially for those patients with nonspecific symptoms after cessation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The risk also varied when stratified for the underlying disease and increased with higher dose (low dose 2.4% (95% CI 0.6-9.3) to high dose 21.5% (95% CI 12.0-35.5)) and longer treatment duration (1.4% (95% CI 0.3-7.4) (<28 days) to 27.4% (95% CI 17.7-39.8) (>1 year)) in patients with asthma.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“A meta-analysis of the risk of developing biochemical glucocorticoid-induced adrenal insufficiency stratified by glucocorticoid route of administration showed pooled percentages of 4.2% (95% CI 0.5-28.9) for nasal administration, 48.7% (95% CI 36.9-60.6) for oral use, and 52.2% (95% CI 40.5-63.6) for intra-articular administration (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Of these 521 patients, 98 patients had biochemical evidence of adrenal insufficiency. Ten of them (10%) reported symptoms. However, 88 (90%) did not report any symptoms”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“In the above-mentioned meta-analysis, ten of the 74 included studies also assessed symptoms of adrenal insufficiency (although not systematically scored) in a total of 521 patients (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
In the citing paper
“Broersen et al performed a meta-analysis on eleven out of seventeen studies re-testing patients for biochemical adrenal insufficiency for which results could be categorized in short-term (defined as less than 4 weeks) high-dose glucocorticoid therapy re-testing after 4 weeks (six studies), and long-term (>1 year) medium-dose glucocorticoid therapy re-testing after 6 months (five studies) (24).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [24]
20 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Oelkers, W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351607 · Cited by 737
Use of oral corticosteroids in the United Kingdom
van Staa, T. P. (2000) · QJM · doi:10.1093/qjmed/93.2.105 · Cited by 529
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
Distinguishing Case Series From Cohort Studies
Dekkers, O. M., Egger, M., Altman, D. G., & Vandenbroucke, J. P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-1-201201030-00006 · Cited by 308
Self-citationSuppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Greenberg, G., Feagan, B., Martin, F., Sutherland, L., Thomson, A., Williams, C., Nilsson, L., & Persson, T. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536887 · Cited by 288
Research works printed but not linked: 1
- Ruiz Munoz, 1988, Adrenocortical function and steroid doses in renal transplant patients, Dial Transplant, 17, 184
Cited by
Birnkrant, D. J., Bushby, K., Bann, C. M., Apkon, S. D., Blackwell, A., Brumbaugh, D., Case, L. E., Clemens, P. R., Hadjiyannakis, S., Pandya, S., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30024-3 · Cited by 1,370
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000002198 · Cited by 1,228
Weiss, S. L., Peters, M. J., Alhazzani, W., Agus, M. S. D., Flori, H. R., Inwald, D. P., Nadel, S., Schlapbach, L. J., Tasker, R. C., Argent, A. C., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05878-6 · Cited by 606
Rhinitis 2020: A practice parameter update
Dykewicz, M. S., Wallace, D. V., Amrol, D. J., Baroody, F. M., Bernstein, J. A., Craig, T. J., Dinakar, C., Ellis, A. K., Finegold, I., Golden, D. B. K., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.007 · Cited by 436
Endocrine toxicities of immune checkpoint inhibitors
Wright, J. J., Powers, A. C., & Johnson, D. B. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00484-3 · Cited by 441
Stress and Obesity: Are There More Susceptible Individuals?
van der Valk, E. S., Savas, M., & van Rossum, E. F. C. (2018) · Current Obesity Reports · doi:10.1007/s13679-018-0306-y · Cited by 402
ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease
Gordon, H., Burisch, J., Ellul, P., Karmiris, K., Katsanos, K., Allocca, M., Bamias, G., Barreiro-de Acosta, M., Braithwaite, T., Greuter, T., et al. (2024) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjad108 · Cited by 318
Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma
Heffler, E., Madeira, L. N. G., Ferrando, M., Puggioni, F., Racca, F., Malvezzi, L., Passalacqua, G., & Canonica, G. W. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.01.025 · Cited by 233
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?
Pofi, R., Caratti, G., Ray, D. W., & Tomlinson, J. W. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad016 · Cited by 209
The cortisol stress response induced by surgery: A systematic review and meta‐analysis
Prete, A., Yan, Q., Al‐Tarrah, K., Akturk, H. K., Prokop, L. J., Alahdab, F., Foster, M. A., Lord, J. M., Karavitaki, N., Wass, J. A., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13820 · Cited by 192
Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review
Joseph, R. M., Hunter, A. L., Ray, D. W., & Dixon, W. G. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.03.001 · Cited by 179
Menzies-Gow, A., Gurnell, M., Heaney, L. G., Corren, J., Bel, E. H., Maspero, J., Harrison, T., Jackson, D. J., Price, D., Lugogo, N., et al. (2022) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00352-0 · Cited by 177
Sivapalan, P., Lapperre, T. S., Janner, J., Laub, R. R., Moberg, M., Bech, C. S., Eklöf, J., Holm, F. S., Armbruster, K., Sivapalan, P., et al. (2019) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(19)30176-6 · Cited by 172
Adrenal Crisis: Still a Deadly Event in the 21st Century
Puar, T. H. K., Stikkelbroeck, N. M. M. L., Smans, L. C. C. J., Zelissen, P. M. J., & Hermus, A. R. M. M. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.08.021 · Cited by 173
A systematic review of the safety and efficacy of systemic corticosteroids in atopic dermatitis
Yu, S. H., Drucker, A. M., Lebwohl, M., & Silverberg, J. I. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2017.09.074 · Cited by 171
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Self-citationInfantile Spasms: Outcome in Clinical Studies
Riikonen, R. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2020.01.015 · Cited by 143
Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults
Betterle, C., Presotto, F., & Furmaniak, J. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01079-6 · Cited by 161
A comprehensive diagnostic approach to detect underlying causes of obesity in adults
van der Valk, E. S., van den Akker, E. L. T., Savas, M., Kleinendorst, L., Visser, J. A., van Haelst, M. M., Sharma, A. M., & van Rossum, E. F. C. (2019) · Obesity Reviews · doi:10.1111/obr.12836 · Cited by 159
Adrenal crisis: prevention and management in adult patients
Dineen, R., Thompson, C. J., & Sherlock, M. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819848218 · Cited by 123
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L. T., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae029 · Cited by 152
Self-citationYealy, D. M., Mohr, N. M., Shapiro, N. I., Venkatesh, A. K., Jones, A. E., & Self, W. H. (2021) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2021.02.006 · Cited by 136
Blakey, J., Chung, L. P., McDonald, V. M., Ruane, L. E., Gornall, J., Barton, C., Bosnic-Anticevich, S. Z., Harrington, J., Hew, M. J., Holland, A. E., et al. (2021) · Respirology · doi:10.1111/resp.14147 · Cited by 114
Local and Systemic Side Effects of Corticosteroid Injections for Musculoskeletal Indications
Kamel, S. I., Rosas, H. G., & Gorbachova, T. (2023) · American Journal of Roentgenology · doi:10.2214/ajr.23.30458 · Cited by 110
Adrenal insufficiency: Physiology, clinical presentation and diagnostic challenges
Martin‐Grace, J., Dineen, R., Sherlock, M., & Thompson, C. J. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.01.029 · Cited by 128
Prete, A., Taylor, A. E., Bancos, I., Smith, D. J., Foster, M. A., Kohler, S., Fazal-Sanderson, V., Komninos, J., O’Neil, D. M., Vassiliadi, D. A., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa133 · Cited by 96
Prevention of complications from use of conventional immunosuppressants: a critical review
Ponticelli, C., & Glassock, R. J. (2019) · Journal of Nephrology · doi:10.1007/s40620-019-00602-5 · Cited by 107
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme
Lisco, G., Tullio, A. D., Stragapede, A., Solimando, A. G., Albanese, F., Capobianco, M., Giagulli, V. A., Guastamacchia, E., Pergola, G. D., Vacca, A., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132920 · Cited by 109
Approach to the Patient: Diagnosis of Cushing Syndrome
Savas, M., Mehta, S., Agrawal, N., van Rossum, E. F. C., & Feelders, R. A. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac492 · Cited by 91
Rational oral corticosteroid use in adult severe asthma: A narrative review
Chung, L. P., Upham, J. W., Bardin, P. G., & Hew, M. J. (2019) · Respirology · doi:10.1111/resp.13730 · Cited by 98
Asthma referrals: a key component of asthma management that needs to be addressed
Price, D. B., Bjermer, L. H., Bergin, D. A., & Martinez, R. H. S. (2017) · Journal of Asthma and Allergy · doi:10.2147/jaa.s134300 · Cited by 90
Bleecker, E. R., Al-Ahmad, M. S., Bjermer, L. H., Caminati, M., Canonica, G. W., Kaplan, A. G., Papadopoulos, N. G., Roche, N., Ryan, D. P., Tohda, Y., et al. (2022) · World Allergy Organization Journal · doi:10.1016/j.waojou.2022.100726 · Cited by 100
Current unmet needs and potential solutions to uncontrolled asthma
Busse, W. W., & Kraft, M. (2022) · European Respiratory Review · doi:10.1183/16000617.0176-2021 · Cited by 89
Mebrahtu, T. F., Morgan, A. W., Keeley, A., Baxter, P. D., Stewart, P. M., & Pujades-Rodriguez, M. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00153 · Cited by 75
Philpott, H., Dougherty, M., Reed, C. C., Caldwell, M., Kirk, D., Torpy, D. J., & Dellon, E. S. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14573 · Cited by 78
Normal Adrenal and Thyroid Function in Patients Who Survive COVID-19 Infection
Clarke, S. A., Phylactou, M., Patel, B., Mills, E., Muzi, B., Izzi‐Engbeaya, C. N., Choudhury, S., Khoo, B. C. E., Meeran, K. M., Comninos, A. N., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab349 · Cited by 75
Kulkarni, S., Durham, H., Glover, L., Ather, O., Phillips, V., Nemes, S., Cousens, L. P., Blomgran, P., & Ambery, P. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061476 · Cited by 90
Oral steroid-sparing effect of high-dose inhaled corticosteroids in asthma
Maijers, I., Kearns, N., Harper, J., Weatherall, M., & Beasley, R. W. (2019) · European Respiratory Journal · doi:10.1183/13993003.01147-2019 · Cited by 76
Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
Patel, R., Naqvi, S. A., Griffiths, C., & Bloom, C. I. (2020) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000756 · Cited by 93
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors
van Iersel, L., Mulder, R. L., Denzer, C., Cohen, L. E., Spoudeas, H. A., Meacham, L. R., Sugden, E., Schouten-van Meeteren, A. Y. N., Hoving, E. W., Packer, R. J., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab040 · Cited by 66
Pofi, R., Feliciano, C., Sbardella, E., Argese, N., Woods, C. P., Grossman, A. B., Jafar-Mohammadi, B., Gleeson, H., Lenzi, A., Isidori, A. M., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00529 · Cited by 67
Rituximab for maintenance of remission in ANCA-associated vasculitis: expert consensus guidelines
Tieu, J., Smith, R., Basu, N., Brogan, P. A., D’Cruz, D. P., Dhaun, N., Floßmann, O., Harper, L., Jones, R. B., Lanyon, P., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez640 · Cited by 72
Home waking salivary cortisone to screen for adrenal insufficiency
Debono, M., Elder, C. J., Lewis, J., Fearnside, J., Caunt, S., Dixon, S., Jacques, R. M., Newell-Price, J., Whitaker, M. J., Keevil, B., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200182 · Cited by 66
(Mis)use of Prescribed Stimulants in the Medical Student Community
Fond, G. B., Gavaret, M., Vidal, C., Brunel, L., Riveline, J., Micoulaud‐Franchi, J., & Domenech, P. (2016) · Medicine · doi:10.1097/md.0000000000003366 · Cited by 64
Borresen, S. W., Klose, M., Baslund, B., Rasmussen, Å. K., Hilsted, L. M., Friis-Hansen, L. J., Locht, H., Hansen, A., Hetland, M. L., Lydolph, M. C., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0251 · Cited by 65
Jensterle, M., Herman, R., Janež, A., Mahmeed, W. A., Al‐Rasadi, K., Al-Alawi, K., Banach, M., Banerjee, Y., Ceriello, A., Cesur, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137326 · Cited by 65
Systemic glucocorticoid use in Denmark: a population-based prevalence study
Laugesen, K., Jørgensen, J. O. L., Sørensen, H. T., & Petersen, I. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015237 · Cited by 61
Self-citationNeuropsychiatric Adverse Effects of Synthetic Glucocorticoids: A Systematic Review and Meta-Analysis
Koning, A.-S. C. A. M., van der Meulen, M., Schaap, D., Satoer, D., Vinkers, C. H., van Rossum, E. F. C., van Furth, W. R., Pereira, A. M., Meijer, O. C., & Dekkers, O. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad701 · Cited by 72
Self-citationCritical Illness–induced Corticosteroid Insufficiency: What It Is Not and What It Could Be
Téblick, A., Gunst, J., & den Berghe, G. V. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac201 · Cited by 65
Perioperative Evaluation and Management of Endocrine Disorders
Himes, C. P., Ganesh, R., Wight, E. C., Simha, V., & Liebow, M. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.004 · Cited by 65
Heickman, L. K. W., Ghajar, L. D., Conaway, M. R., & Rogol, A. D. (2018) · Hormone Research in Paediatrics · doi:10.1159/000489125 · Cited by 59
Savas, M., Muka, T., Wester, V. L., van den Akker, E. L. T., Visser, J. A., Braunstahl, G.-J., Slagter, S. N., Wolffenbuttel, B. H. R., Franco, O. H., & van Rossum, E. F. C. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01133 · Cited by 58
Andersen, Y. M. F., Egeberg, A., Ban, L., Gran, S., Williams, H. C., Francis, N. A., Knop, F. K., Gislason, G., Skov, L., & Thyssen, J. P. (2019) · Diabetes Care · doi:10.2337/dc18-2158 · Cited by 65
Savas, M., Vinkers, C. H., Rosmalen, J. G. M., Hartman, C. A., Wester, V. L., van den Akker, E. L. T., Iyer, A. M., McEwen, B. S., & van Rossum, E. F. C. (2020) · Neuroendocrinology · doi:10.1159/000501617 · Cited by 55
Noetzlin, S., Bréville, G., Seebach, J. D., & Gastaldi, G. (2022) · Swiss Medical Weekly · doi:10.4414/smw.2022.w30088 · Cited by 68
Struja, T., Briner, L., Meier, A., Kutz, A., Mundwiler, E., Huber, A., Müeller, B., Bernasconi, L., & Schüetz, P. (2017) · Endocrine Practice · doi:10.4158/ep171861.or · Cited by 54
What we have to know about corticosteroids use during Sars-Cov-2 infection
Ferraù, F., Ceccato, F., Cannavò, S., & Scaroni, C. M. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01384-5 · Cited by 54
Central adrenal insufficiency: open issues regarding diagnosis and glucocorticoid treatment
Ceccato, F., & Scaroni, C. M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0824 · Cited by 55
How can we minimise the use of regular oral corticosteroids in asthma?
BOURDIN, A. A., Adcock, I. M., Berger, P., Bonniaud, P., Chanson, P., Chenivesse, C., Jacques de, B. L. I. C., Deschildre, A., Devillier, P., Devouassoux, G., et al. (2020) · European Respiratory Review · doi:10.1183/16000617.0085-2019 · Cited by 53
Pelewicz, K., & Miśkiewicz, P. (2021) · Diagnostics · doi:10.3390/diagnostics11040728 · Cited by 44
Severe asthma: oral corticosteroid alternatives and the need for optimal referral pathways
Cataldo, D. D., Louis, R. E., Michils, A., Peché, R., Pilette, C., Schleich, F., Ninane, V., & Hanon, S. (2020) · Journal of Asthma · doi:10.1080/02770903.2019.1705335 · Cited by 45
Gurnell, M., Heaney, L. G., Price, D., & Menzies-Gow, A. N. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13273 · Cited by 51
Steroid use and misuse: a key performance indicator in the management of IBD
Blackwell, J., Selinger, C. P., Raine, T., Parkes, G. C., Smith, M. A., & Pollok, R. (2020) · Frontline Gastroenterology · doi:10.1136/flgastro-2019-101288 · Cited by 50
Group 2: Adrenal insufficiency: screening methods and confirmation of diagnosis
Chanson, P., Guignat, L., Goichot, B., Chabre, O., Samara‐Boustani, D., Reynaud, R., Simon, D., Tabarin, A., Gruson, D., Reznik, Y., et al. (2017) · Annales d Endocrinologie · doi:10.1016/j.ando.2017.10.005 · Cited by 43
Glucocorticoid withdrawal syndrome: what to expect and how to manage
Theiler‐Schwetz, V., & Prete, A. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000804 · Cited by 45
Truyens, M., Lernout, H., Vos, M. D., Laukens, D., & Lobatón, T. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1424926 · Cited by 46
Air pollution and resistance to inhaled glucocorticoids: Evidence, mechanisms and gaps to fill
Rider, C. F., & Carlsten, C. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.005 · Cited by 41
Wester, V. L., Noppe, G., Savas, M., van den Akker, E. L. T., de Rijke, Y. B., & van Rossum, E. F. C. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.02.024 · Cited by 44
Approach to the Patient With Glucocorticoid-induced Adrenal Insufficiency
Borresen, S. W., Klose, M., Glintborg, D., Watt, T., Andersen, M., & Feldt‐Rasmussen, U. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac151 · Cited by 47
Endocrine Emergencies With Neurologic Manifestations
Ishii, M. (2017) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000467 · Cited by 39
Nonrespiratory Comorbidities in Asthma
Cardet, J. C., Bulkhi, A. A., & Lockey, R. F. (2021) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.08.027 · Cited by 44
Systematic Evaluation of Corticosteroid Use in Obese and Non-obese Individuals: A Multi-cohort Study
Savas, M., Wester, V. L., Staufenbiel, S. M., Koper, J. W., van den Akker, E. L. T., Visser, J. A., van der Lely, A. J., Penninx, B. W. J. H., & van Rossum, E. F. C. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.19213 · Cited by 42
Feuerstein, J. D., Rubin, D. T., Aberra, F. N., Yarur, A. J., & Malter, L. B. (2025) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2025.05.019 · Cited by 44
Iatrogenic adrenal insufficiency in adults
Martin‐Grace, J., Tomkins, M., O’Reilly, M., & Sherlock, M. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00929-x · Cited by 40
“Intra-articular glucocorticoid administration is associated with a high risk of TAI (absolute risk 52.2, 95% CI 40.5–63.6) 114 , and HPA axis suppression can occur following a single intra-articular injection 146 .”
InfluentialSagar, R. C., Mackie, S. L., Morgan, A. W., Stewart, P. M., & Abbas, A. (2020) · Clinical Endocrinology · doi:10.1111/cen.14405 · Cited by 38
High Mortality Rate in Oral Glucocorticoid Users: A Population-Based Matched Cohort Study
Einarsdottir, M. J., Ekman, P., Molin, M., Trimpou, P., Olsson, D. S., Johannsson, G., & Ragnarsson, Ó. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.918356 · Cited by 34
Laugesen, K., Broersen, L. H. A., Hansen, S. B., Dekkers, O. M., Sørensen, H. T., & Jorgensen, J. O. L. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1199 · Cited by 32
Self-citationPerioperative evaluation and management of patients on glucocorticoids
Chen Cardenas, S. M., Santhanam, P., Morris-Wiseman, L., Salvatori, R., & Hamrahian, A. H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac185 · Cited by 31
Assa, A., Aloi, M., Biervliet, S. V., Bronský, J., de Carpi, J. M., Gasparetto, M., Gianolio, L., Gordon, H., Hojsak, I., Hudson, A. S., et al. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70096 · Cited by 35
Laugesen, K., Petersen, I., Sørensen, H. T., & Jørgensen, J. O. L. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212259 · Cited by 30
Self-citationBorresen, S. W., Thorgrimsen, T. B., Jensen, B., Hilsted, L., Bartels, E. M., Feldt‐Rasmussen, U., & Locht, H. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa011 · Cited by 31
Duan, L., Feng, X., Zhang, R., Tan, X., Xiang, X., Shen, R., & Zheng, H. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0096 · Cited by 31
Latent Adrenal Insufficiency: Concept, Clues to Detection, and Diagnosis
Yamamoto, T. (2018) · Endocrine Practice · doi:10.4158/ep-2018-0114 · Cited by 36
Is there a safe and effective way to wean patients off long‐term glucocorticoids?
Baker, E. H. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14679 · Cited by 38
Aronson, K. I., Martin-Schwarze, A. M., Swigris, J. J., Kolenic, G. E., Krishnan, J. K., Podolanczuk, A. J., Kaner, R. J., Martínez, F. J., Safford, M. M., & Pinheiro, L. C. (2023) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202208-1504oc · Cited by 30
Possible Adrenal Involvement in Long COVID Syndrome
Salzano, C., Saracino, G., & Cardillo, G. (2021) · Medicina · doi:10.3390/medicina57101087 · Cited by 27
Moritz, M., & Geszke-Moritz, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081542 · Cited by 32
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
McDowell, P. J., Stone, J. H., Zhang, Y., Honeyford, K., Dunn, L., Logan, R. J., McGarvey, L. P., Butler, C. A., & Heaney, L. G. (2021) · European Respiratory Journal · doi:10.1183/13993003.00160-2021 · Cited by 27
Glucocorticoid treatment and adrenal suppression in children: current view and open issues
Improda, N., Chioma, L., Capalbo, D., Bizzarri, C., & Salerno, M. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02461-9 · Cited by 35
Inflammation, immunity and potential target therapy of SARS-COV-2: A total scale analysis review
Smail, S. W., Saeed, M., Alkasalias, T., Khudhur, Z. O., Younus, D. A., Rajab, M. F., Abdulahad, W. H., Hussain, H. I., Niaz, K., & Safdar, M. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112087 · Cited by 27
Omalizumab: An Optimal Choice for Patients with Severe Allergic Asthma
Kotoulas, S., Tsiouprou, I., Fouka, E., Pataka, A., Papakosta, D., & Porpodis, Κ. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020165 · Cited by 28
Hou, H., Li, Y., Xu, Z., Yu, Z., Peng, B., Wang, C., Liu, W., Li, W., Ye, Z., & Zhang, G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113933 · Cited by 27
Melani, A. S., Croce, S., Cassai, L., Montuori, G., Fabbri, G., Messina, M., Viani, M., & Bargagli, E. (2023) · Pulmonary Therapy · doi:10.1007/s41030-023-00227-x · Cited by 25
Karangizi, A. H. K., Al-Shaghana, M., Logan, S., Criseno, S., Webster, R., Boelaert, K., Hewins, P., & Harper, L. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1354-6 · Cited by 23
Benzon, H. T., Provenzano, D. A., Nagpal, A., Souza, D., Eckmann, M. S., Nelson, A. M., Mina, M., Abd-Elsayed, A. A., Elmofty, D. H., Chadwick, A. L., et al. (2025) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2024-105656 · Cited by 36
Jackson, D. J., Lugogo, N. L., Gurnell, M., Heaney, L. G., Korn, S., Brusselle, G., Chanez, P., del Olmo, R., Llanos, J., Keeling, N., et al. (2025) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(25)00359-5 · Cited by 30
Einarsdottir, M. J., Ekman, P., Trimpou, P., Olsson, D. S., Johannsson, G., & Ragnarsson, Ó. (2019) · Clinical Endocrinology · doi:10.1111/cen.14114 · Cited by 25
Managing Corticosteroid-Related Comorbidities in Severe Asthma
Sood, V., Rogers, L., & Khurana, S. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.05.021 · Cited by 27
Metadata
- Authors
- Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M.
- Affiliations
- Leiden University Medical Center (NL)
- Aarhus University (DK)
- Corresponding author
- Dekkers, Olaf M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06-01
- Volume
- 100
- Issue
- 6
- Pages
- 2171-2180
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2022140603
- Cited by
- 456
- References
- 98
- Citations by year
- 2026: 39 · 2025: 53 · 2024: 50 · 2023: 55 · 2022: 52 · 2021: 48 · 2020: 53 · 2019: 39 · 2018: 28 · 2017: 20 · 2016: 14 · 2015: 5
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Funders
- Novo Nordisk Fonden (NNF-13OC0007869)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- adrenal insufficiency, glucocorticoid-induced adrenal insufficiency, corticosteroid use, glucocorticoid dose, treatment duration, route of administration, intra-articular corticosteroids, inhaled corticosteroids, asthma, hematologic malignancies, adrenal function testing
- MeSH terms
- Adrenal Cortex Hormones, Adrenal Insufficiency, Adult, Dosage Forms, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Administration Schedule, Humans, Inflammation, Neoplasms, Skin Diseases, Organ Transplantation, Transplantation Conditioning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.